usapl bpc 157 rules ⚠️Peptides and synthetic peptides are being sold as “wellness” products, but make no mistake: they are performance-enhancing drugs and prohibited by WADA and USAPL. #TrueToTheMission #LiftClean #USAPL #USAPowerlifting BPC-157

Geldenhuys W, Wehrung D, Groshev A, Hirani A, Sutariya V

Lyophilized peptides tolerate room temperature shipping well

Montagne A, Barnes SR, Sweeney MD, Halliday MR, Sagare AP, Zhao Z, et al

Compounded medications have not been approved by the FDA for safety, effectiveness, or quality and should only be used when FDA-approved medications are unavailable

For researchers building a longevity-focused order, the practical sequence is: identify the pathway under study, select the matching compound, and verify material quality before relying on the data it produces

The Role of Triple and Quadruple Agonism The concept of cagrilintide dosage with tirzepatide represents potential quadruple pathway activation: GIP pathway (via tirzepatide) GLP-1 pathway (via tirzepatide) Amylin pathway (via cagrilintide) Potential synergistic effects across all three While no clinical data yet exists for this specific combination, the success of dual and triple agonist approaches suggests that carefully designed multi-pathway interventions may represent the future of metabolic medicine